Radetec Diagnostics

Radetec Diagnostics is a Melbourne-based bio-nanotechnology company that specializes in the production and application of highly fluorescent quantum dot nanoparticles. These nanoparticles are engineered to be stable in buffers and can be conjugated with various biologically active molecules, such as antibodies. Beyond nanoparticle synthesis, the company develops specialized laboratory equipment for lateral flow assay development, including automated stripers for protein application on nitrocellulose and electronic readers for fluorescence and colorimetric quantification. By combining this proprietary nanotechnology with molecular and serological assays, Radetec creates highly sensitive, cost-effective point-of-care diagnostic tools.

These innovations are primarily directed toward revolutionizing the detection of infectious diseases, including sexually transmitted infections and animal health conditions. The company’s diagnostic platform aims to improve accessibility to rapid, private testing, helping to mitigate the societal stigma and high costs associated with traditional lab-based molecular testing. Through research partnerships and custom synthesis services, Radetec also supports the broader scientific community in developing tailored nanomaterials and lateral flow applications for various biomedical and industrial research needs.